Cargando…

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with reproductive and metabolic abnormalities. The aim of this study was to analyse risk of cardiovascular disease (CVD) in PCOS, to define individual risk factors and assess their ability to predict risk. METHODS: Fifty-four young women wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blagojevic, Iva Perovic, Eror, Tatjana, Pelivanovic, Jovana, Jelic, Svetlana, Kotur-Stevuljevic, Jelena, Ignjatovic, Svetlana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287215/ https://www.ncbi.nlm.nih.gov/pubmed/30568543 http://dx.doi.org/10.1515/jomb-2017-0020

Ejemplares similares

Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity
por: Blagojević, Iva Perović, et al.
Publicado: (2018)

Undiagnosed Hyperglycaemia and Hypertension as Indicators of the Various Risk Factors of Future Cardiovascular Disease Among Population of Serbian Students
por: Georgiev, Andrijana Milošević, et al.
Publicado: (2018)

Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome
por: Morotti, Elena, et al.
Publicado: (2014)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
por: Spremović Rađenović, Svetlana, et al.
Publicado: (2022)

Oxidative Stress and Inflammatory Biomarkers in Patients with Diabetic Foot
por: Vujčić, Sanja, et al.
Publicado: (2022)

The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome
por: Safi, Aigul, et al.
Publicado: (2020)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Relationship between Cardiovascular Risk Score and Traditional and Nontraditional Cardiometabolic Parameters in Obese Adolescent Girls
por: Klisic, Aleksandra, et al.
Publicado: (2016)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
por: Lo, Andre C Q, et al.
Publicado: (2023)

Cardiovascular Risk Factors in 7–13 Years Old Children from Vojvodina (Serbia)
por: Dželajlija, Darko D., et al.
Publicado: (2016)

Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
por: Sarić-Matutinović, Marija, et al.
Publicado: (2022)

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2018)

Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome
por: Duică, Florentina, et al.
Publicado: (2021)

Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview
por: Rathi, Netal, et al.
Publicado: (2023)

Alteration in Redox Status and Lipoprotein Profile in COVID-19 Patients with Mild, Moderate, and Severe Pneumonia
por: Lalosevic, Miodrag, et al.
Publicado: (2022)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Autonomic dysfunction in women with polycystic ovary syndrome
por: Hashim, Zainab Hasan, et al.
Publicado: (2015)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

An overview of polycystic ovary syndrome in aging women
por: Çelik, Özlem, et al.
Publicado: (2021)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
por: Dybciak, Paweł, et al.
Publicado: (2022)

Hepatic steatosis in women with polycystic ovary syndrome
por: Hong, Xinyu, et al.
Publicado: (2023)

Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study
por: Berni, Thomas R, et al.
Publicado: (2021)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine
por: Mohamadin, Ahmed M., et al.
Publicado: (2010)

Coronary artery disease risk in young women with polycystic ovary syndrome
por: Ding, Dah-Ching, et al.
Publicado: (2018)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia
por: Shaman, Amani Ali, et al.
Publicado: (2017)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Comparison of Lifestyle in Women With Polycystic Ovary Syndrome and Healthy Women
por: Sedighi, Sedigheh, et al.
Publicado: (2015)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome
por: Dhaliwal, Lakhbir Kaur, et al.
Publicado: (2011)

Vitamin D deficiency in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sqjjc2ufsh4noe28and5otnrgk